Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Czechia / NCT07353710
Recruiting Not applicable

A Study on the Acquisition of 2D ICE Images With the CHORUS IDx System in Subjects Undergoing an Ablation Procedure

NCT07353710 · tracked via the Priya Life Science Czechia tracker
Phase
Not applicable
Started
2026-07-28
Last updated
2026-09-24

Condition(s) studied

Atrial ArrhythmiaIntracardiac Echocardiography

Investigational drug(s) / intervention(s)

ICE Image Acquisition

ICE Image Acquisition: ICE image acquisition using the investigational device

Study summary

A first-in-human prospective data collection study including subjects who are planned to undergo an ablation procedure for any atrial arrhythmia as per medical judgement and the site's standard practice, represents the most viable means to collect human anatomy ICE images for the purpose of software development.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Subjects who are able and willing to provide written informed consent prior to any study procedure. 2. Subjects who are planned for an ablation procedure for any atrial arrhythmia using any commercially available Boston Scientific Ablation System, per physician's judgement and hospitals' standard practice. 3. Subjects who are willing and able to participate in all testing and assessments associated with this clinical study at an approved clinical investigation center. 4. Subjects whose age is 18 years or above, or who are of legal age to give informed consent specific to state and national law. Exclusion Criteria: 1. Any of the following cardiac implanted devices * Any prosthetic mitral or tricuspid heart valve, such as ring, repairs or clips * Atrial septal defect (ASD) occluders including interatrial baffle, closure device, patch, or patent foramen ovale or ASD occluder 2. Subjects with contraindications related to the use of the CHORUS IDx™ System: * Subjects with inadequate vascular access * Subjects with active systemic infection * Subjects with presence of a known intracardiac thrombus in the chamber of use 3. Women who are confirmed to be pregnant or lactating at the time of the Index Procedure 4. Presence of other medical conditions, that, in the investigator's opinion, could limit the subject's ability to participate in the study 5. Subjects who are currently enrolled in another investigational study or registry that would directly interfere with the current study, except when the subject is participating in a mandatory governmental registry, or a purely observational registry with no associated treatments; each instance must be brought to the attention of the Sponsor to determine eligibility

Primary outcome measure(s)

Trial sites (8)

FacilityCityRegionStatus
Lingard Private Hospital Merewether Australia Not Yet Recruiting
Klinicki Bolnicki Centar Split Split Croatia Recruiting
IKEM - Institut klinicke a experimentalni mediciny Prague Czechia Not Yet Recruiting
Hygeia Hospital Athens Greece Not Yet Recruiting
Institut Jantung Negara Kuala Lumpur Malaysia Not Yet Recruiting
Auckland City Hospital Auckland New Zealand Not Yet Recruiting
Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego Warsaw Poland Not Yet Recruiting
National Heart Center Singapore Singapore Singapore Recruiting

More Boston Scientific Corporation trials in Czechia

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07353710 on ClinicalTrials.gov ↗ ← All trials in Czechia